- Companies
- Luyan Pharma
Luyan Pharma Valuation Multiples
Luyan Pharma is valued at $562M as of November 2026, a 0.4x revenue multiple. In the last fiscal year, Luyan Pharma revenue was $3.2B and Luyan Pharma EBITDA was $104M.
Luyan Pharma Overview
About Luyan Pharma
Luyan Pharma Co Ltd engages in the production, operation, distribution, and retail of human health products in China. It provides medical and health products.
Founded
2008
HQ
Employees
5.6K
Website
Sectors
Financials (Last FY)
EV
$1.3B
Valuation Multiples
Start free trialLuyan Pharma Financials
Luyan Pharma reported last fiscal year revenue of $3.2B and EBITDA of $104M.
In the same fiscal year, Luyan Pharma generated $226M in gross profit, $104M in EBITDA, and $42M in net income.
Luyan Pharma P&L
In the most recent fiscal year, Luyan Pharma reported revenue of $3.2B and EBITDA of $104M.
Luyan Pharma is profitable as of last fiscal year, with gross margin of 7%, EBITDA margin of 3%, and net margin of 1%.
Financial data powered by Morningstar, Inc.
Luyan Pharma Stock Performance
Luyan Pharma has current market cap of $562M, and enterprise value of $1.3B.
Market Cap Evolution
Luyan Pharma's stock price is $1.45.
Luyan Pharma share price increased by 2.5% in the last 30 days, and by 5.7% in the last year.
Luyan Pharma has an EPS (earnings per share) of $0.11.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.3B | $562M | 2.5% | 2.5% | -10.1% | 5.7% | $0.11 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLuyan Pharma Valuation Multiples
Luyan Pharma trades at 0.4x EV/Revenue multiple, and 12.1x EV/EBITDA.
Luyan Pharma Financial Valuation Multiples
As of November 3, 2026, Luyan Pharma has market cap of $562M and EV of $1.3B.
Luyan Pharma has a P/E ratio of 13.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Luyan Pharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Luyan Pharma Margins & Growth Rates
In the most recent fiscal year, Luyan Pharma reported gross margin of 7%, EBITDA margin of 3%, and net margin of 1%.
Luyan Pharma Margins
Luyan Pharma Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Luyan Pharma Operational KPIs
Luyan Pharma's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Luyan Pharma Competitors
Luyan Pharma competitors include Cawachi, Zjamp Group, American Oncology Network, Cachet Pharmaceuticals, Genky Drug Stores, Entero Healthcare Solutions, Medplus Health Services, Selçuk Ecza, Pague Menos and JZJ Chain Drugstore.
Most Luyan Pharma public comparables operate across Pharmacies.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $1.8B | $64M | 0.2x | 0.2x | 6.3x | - | |||
| $7.1B | $249M | 0.1x | - | 2.8x | - | |||
| $1.8B | ($1M) | 0.4x | - | (465.6x) | - | |||
| $2.9B | $66M | 0.2x | - | 7.6x | - | |||
| $1.4B | $118M | 0.6x | 0.6x | 7.0x | 7.1x | |||
| $689M | $27M | 1.1x | 1.0x | 28.3x | 20.4x | |||
| $720M | $67M | 1.2x | 1.0x | 12.5x | 14.7x | |||
| $3.4B | $40M | 0.2x | 0.1x | 16.8x | 5.8x | |||
This data is available for Pro users. Sign up to see all Luyan Pharma competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Luyan Pharma
| When was Luyan Pharma founded? | Luyan Pharma was founded in 2008. |
| Where is Luyan Pharma headquartered? | Luyan Pharma is headquartered in China. |
| How many employees does Luyan Pharma have? | As of today, Luyan Pharma has over 5K employees. |
| Is Luyan Pharma publicly listed? | Yes, Luyan Pharma is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Luyan Pharma? | Luyan Pharma trades under 002788 ticker. |
| When did Luyan Pharma go public? | Luyan Pharma went public in 2016. |
| Who are competitors of Luyan Pharma? | Luyan Pharma main competitors include Cawachi, Zjamp Group, American Oncology Network, Cachet Pharmaceuticals, Genky Drug Stores, Entero Healthcare Solutions, Medplus Health Services, Selçuk Ecza, Pague Menos, JZJ Chain Drugstore. |
| What is the current market cap of Luyan Pharma? | Luyan Pharma's current market cap is $562M. |
| What is the current revenue of Luyan Pharma? | Luyan Pharma's last fiscal year revenue is $3.2B. |
| What is the current EV/Revenue multiple of Luyan Pharma? | Current revenue multiple of Luyan Pharma is 0.4x. |
| Is Luyan Pharma profitable? | No, Luyan Pharma is not profitable. |
| How many companies Luyan Pharma has acquired to date? | Luyan Pharma hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Luyan Pharma has invested to date? | Luyan Pharma hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Luyan Pharma
Lists including Luyan Pharma
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




